Bone metastases in lung cancer: Potential novel approaches to therapy

Silvestre Vicent, Naiara Perurena, Ramaswamy Govindan, Fernando Lecanda

Research output: Contribution to journalArticlepeer-review

24 Scopus citations


The skeleton is a common site of metastases in lung cancer, an event associated with significant morbidities and poor outcomes. Current antiresorptive therapies provide limited benefit, and novel strategies of prevention and treatment are urgently needed. This review summarizes the latest advances and new perspectives on emerging experimental and clinical approaches to block this deleterious process. Progress propelled by preclinical models has led to a deeper understanding on the complex interplay of tumor cells in the osseous milieu, unveiling potential new targets for drug development. Improvements in early diagnosis through the use of sophisticated imaging techniques with bone serum biomarkers are also discussed in the context of identifying patients at risk and monitoring disease progression during the course of treatment.

Original languageEnglish
Pages (from-to)799-809
Number of pages11
JournalAmerican journal of respiratory and critical care medicine
Issue number7
StatePublished - Oct 1 2015


  • Biomarkers
  • Clinical trials
  • Tyrosine kinase inhibitor


Dive into the research topics of 'Bone metastases in lung cancer: Potential novel approaches to therapy'. Together they form a unique fingerprint.

Cite this